Effects of polysulfated glycosaminoglycan and triamcinolone acetonid on the production of proteinases and their inhibitors by IL-1alpha treated articular chondrocytes
- PMID: 12123742
- DOI: 10.1016/s0006-2952(02)01073-0
Effects of polysulfated glycosaminoglycan and triamcinolone acetonid on the production of proteinases and their inhibitors by IL-1alpha treated articular chondrocytes
Abstract
In this study we determined the in vitro effects of polysulfated glycosaminoglycan (PSGAG) and the glucocorticoid triamcinolone acetonid (TA) on the IL-1 altered expression and activity of matrix metalloproteinases (MMP-1, MMP-3), tissue inhibitor of metalloproteinases-1, the plasminogen activators tPA and uPA and plasminogen activator inhibitor 1 by articular chondrocytes. Bovine chondrocytes were cultured in alginate gel beads. Cells were treated with interleukin-1alpha (IL-1alpha) in the presence of vehicle or drugs at various concentrations. After 48hr mRNA expression of MMP-1, MMP-3, TIMP-1, uPA, tPA and PAI-1 was analyzed by RT-PCR-ELISA. The protein synthesis of TIMP-1 and MMP-3 was determined by immunoprecipitation, PAI-1 protein was quantitated by ELISA. The activity of enzymes and inhibitors was measured by functional assays. Treating chondrocytes with IL-1 induced the expression of MMPs and downregulated TIMP-1 but stimulated both the expression of PAs and PAI-1. Both drugs significantly reduced collagenase and proteoglycanase activities which was accompanied by inhibition of the expression of MMP-1 and MMP-3. The IL-1 decreased expression of TIMP-1 was further reduced by TA, which resulted in a significant loss of TIMP activity. No effects on TIMP activity or TIMP-1 biosynthesis were observed after treatment of chondrocytes with PSGAG. Both drugs inhibited the IL-1-induced mRNA expression of tPA, whereas expression of uPA was only mildly reduced by PSGAG, which also induced PAI-1 above IL-1 stimulated levels. As inhibition of collagenase activities and tPA expression by PSGAG occurred at physiological concentrations it might be of clinical relevance, indicating that PSGAG could help reducing cartilage degradation and has a strong anti-fibrinolytic potential. Due to their co-regulation of MMPs and TIMP(s) glucocorticoids should be carefully studied for their overall effect on extracellular matrix proteolysis.
Similar articles
-
Effects of non-steroidal antiinflammatory drugs and dexamethasone on the activity and expression of matrix metalloproteinase-1, matrix metalloproteinase-3 and tissue inhibitor of metalloproteinases-1 by bovine articular chondrocytes.Osteoarthritis Cartilage. 2001 Jul;9(5):407-15. doi: 10.1053/joca.2000.0406. Osteoarthritis Cartilage. 2001. PMID: 11467888
-
Effects of tetracyclines on the production of matrix metalloproteinases and plasminogen activators as well as of their natural inhibitors, tissue inhibitor of metalloproteinases-1 and plasminogen activator inhibitor-1.Inflamm Res. 2001 Mar;50(3):175-82. doi: 10.1007/s000110050742. Inflamm Res. 2001. PMID: 11339506
-
Differential effects of nonsteroidal antiinflammatory drugs on the IL-1 altered expression of plasminogen activators and plasminogen activator inhibitor-1 by articular chondrocytes.Inflamm Res. 2002 Aug;51(8):427-33. doi: 10.1007/pl00000325. Inflamm Res. 2002. PMID: 12234061
-
Differential expression of matrix metalloproteinases and their physiological inhibitors in acute murine skin wounds.Arch Dermatol Res. 1998 Jul;290 Suppl:S24-9. doi: 10.1007/pl00007450. Arch Dermatol Res. 1998. PMID: 9710380 Review.
-
Different roles for plasminogen activators and metalloproteinases in melanoma metastasis.Curr Top Microbiol Immunol. 1996;213 ( Pt 1):65-80. doi: 10.1007/978-3-642-61107-0_5. Curr Top Microbiol Immunol. 1996. PMID: 8814995 Review.
Cited by
-
Effect of chondroitin sulphate in a rabbit model of atherosclerosis aggravated by chronic arthritis.Br J Pharmacol. 2008 Jun;154(4):843-51. doi: 10.1038/bjp.2008.113. Epub 2008 Apr 21. Br J Pharmacol. 2008. PMID: 18536737 Free PMC article.
-
Anti-Vascular Endothelial Growth Factor Therapy with or Without Initial Steroid Therapy for Macular Edema in Branch Retinal Vein Occlusion.Clin Ophthalmol. 2023 Aug 9;17:2267-2275. doi: 10.2147/OPTH.S418843. eCollection 2023. Clin Ophthalmol. 2023. PMID: 37581097 Free PMC article.
-
Verteporfin photodynamic therapy combined with intravitreal triamcinolone for choroidal neovascularization due to angioid streaks.Clin Ophthalmol. 2010 Jun 24;4:525-30. doi: 10.2147/opth.s10649. Clin Ophthalmol. 2010. PMID: 20596507 Free PMC article.
-
Vitreous inflammatory factors in macular edema with central retinal vein occlusion.Jpn J Ophthalmol. 2011 May;55(3):248-255. doi: 10.1007/s10384-011-0016-4. Epub 2011 May 3. Jpn J Ophthalmol. 2011. PMID: 21538003
-
Aqueous flare and inflammatory factors in macular edema with central retinal vein occlusion: a case series.BMC Ophthalmol. 2013 Dec 11;13:78. doi: 10.1186/1471-2415-13-78. BMC Ophthalmol. 2013. PMID: 24325604 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous